Research Use Only — Not for Human or Veterinary Use.
Sign in
‹ Library

Tesamorelin + Ipamorelin Blend

Blend & StackResearch Use Only

Also known as: Tesa + Ipa Blend

This blend pairs Tesamorelin (a stabilized GHRH analog that is an approved prescription drug in some jurisdictions) with Ipamorelin. In research literature the two are studied for complementary action on the growth-hormone axis, with Tesamorelin representing a GHRH-analog pathway and Ipamorelin a selective secretagogue pathway.

Typical range (research)
Commonly referenced research ranges per component: Tesamorelin around 1-2 mg per administration; Ipamorelin around 100-200 mcg per administration. The 10 mg total is split across both peptides by formulation.
Half-life
Varies by component
Route
Subcutaneous (research)
Common use
Growth-hormone axis and body-composition research
Common vial sizes
10 mg total
Storage
Refrigerate reconstituted solution at 2-8 C; keep powder cold until reconstitution.
Stacking notes
Components: Tesamorelin, Ipamorelin.

Reported side effects

Injection-site irritationFluid retention reported anecdotallyJoint discomfort reported anecdotallyHuman data limited
Regulatory note: Tesamorelin is an approved prescription drug in some jurisdictions, including Canada; a component of this blend is therefore a regulated pharmaceutical.
Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.